COVID-19 Impact on Preclinical Imaging (In-VIVO) Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2021-2027

The Global Preclinical Imaging (In-VIVO) Market size is expected to grow at an annual average of 5.3% during 2021-2027. Preclinical imaging is the visualization of living animals for research purposes such as drug development. Imaging modalities have long been important to researchers observing changes at the organ, tissue, cellular or molecular level in animals in response to physiological or environmental changes. Non-invasive and in vivo imaging modalities have become particularly important for longitudinal study of animal models.

The following Segmentation are covered in this report:

by Modality

• Optical Imaging Systems
• Preclinical Nuclear Imaging Systems
• Micro-MRI Systems
• Micro-Ultrasound Systems
• Micro-CT Systems
• Preclinical Photoacoustic Imaging Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems

by Reagents

• Preclinical Optical Imaging Reagents
• Preclinical Nuclear Imaging Reagents
• Preclinical MRI Contrast Agents
• Preclinical Ultrasound Contrast Agents
• Preclinical CT Contrast Agents

Scope of the Report

The research study analyses the global Preclinical Imaging (In-VIVO) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

• Market Overview and growth analysis
• Import and Export Overview
• Volume Analysis
• Current Market Trends and Future Outlook
• Market Opportunistic and Attractive Investment Segment

Geographic Coverage

• North America Market Size and/or Volume
• Latin America Market Size and/or Volume
• Europe Market Size and/or Volume
• Asia-Pacific Market Size and/or Volume
• Rest of the world Market Size and/or Volume